Apr 30 |
FDA approves Labcorp companion diagnostic for Pfizer gene therapy
|
Apr 30 |
Pfizer, Genmab cervical cancer therapy wins full FDA approval
|
Apr 30 |
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
|
Apr 30 |
Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead
|
Apr 30 |
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
|
Apr 29 |
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
|
Apr 29 |
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
|
Apr 29 |
Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1?
|
Apr 29 |
UPDATE 1-US FDA grants full approval for Pfizer's cervical cancer drug
|
Apr 29 |
These 3 High-Yield Stocks Have Been Growing Their Dividends Non-Stop, And Analysts Expect Their Share Prices To Climb
|